Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells

被引：0

作者：

Uguen, Melanie ^{[1
]}

Shell, Devan J. ^{[1
]}

Silva, Madhushika ^{[2
]}

Deng, Yu ^{[3
,4
]}

Li, Fengling ^{[2
]}

Szewczyk, Magdalena M. ^{[2
]}

Yang, Ka ^{[5
]}

Zhao, Yani ^{[1
]}

Stashko, Michael A. ^{[1
]}

Norris-Drouin, Jacqueline L. ^{[1
]}

Waybright, Jarod M. ^{[1
,7
]}

Beldar, Serap ^{[2
]}

Rectenwald, Justin M. ^{[1
]}

Mordant, Angie L. ^{[6
]}

Webb, Thomas S. ^{[6
]}

Herring, Laura E. ^{[6
]}

Arrowsmith, Cheryl H. ^{[2
]}

Ackloo, Suzanne ^{[2
]}

Gygi, Steven P. ^{[5
]}

Mcginty, Robert K. ^{[1
,3
,4
]}

Barsyte-Lovejoy, Dalia ^{[2
]}

Liu, Pengda ^{[3
,4
]}

Halabelian, Levon ^{[2
]}

James, Lindsey I. ^{[1
,3
]}

Pearce, Kenneth H. ^{[1
,3
]}

Frye, Stephen V. ^{[1
,3
]}

机构：

[1] Univ North Carolina Chapel Hill, Ctr Integrat Chem Biol & Drug Discovery, UNC Eshelman Sch Pharm, Chem Biol & Med Chem, Chapel Hill, NC 27599 USA

[2] Univ Toronto, Toronto, ON, Canada

[3] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA

[4] Univ North Carolina Chapel Hill, Dept Biochem & Biophys, Chapel Hill, NC USA

[5] Harvard Med Sch, Dept Cell Biol, Boston, MA USA

[6] Univ North Carolina Chapel Hill, Dept Pharmacol, UNC Metabol & Prote Core Facil, Chapel Hill, NC USA

[7] Design Therapeut, Carlsbad, CA USA

来源：

NATURE COMMUNICATIONS | 2025年 / 16卷 / 01期

基金：

加拿大健康研究院; 加拿大创新基金会; 加拿大自然科学与工程研究理事会; 美国国家卫生研究院;

关键词：

D O I：

10.1038/s41467-025-57005-3

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

A promising drug target, SETDB1, is a dual methyl-lysine (Kme) reader and methyltransferase implicated in cancer and neurodegenerative disease progression. To help understand the role of the triple Tudor domain (3TD) of SETDB1, its Kme reader, we first identify a low micromolar potency small molecule ligand, UNC6535, which occupies simultaneously both the TD2 and TD3 reader binding sites. Further optimization leads to the discovery of UNC10013, a covalent 3TD ligand targeting Cys385 of SETDB1. UNC10013 is potent with a kinact/KI of 1.0 x 106 M-1s-1 and demonstrates proteome-wide selectivity. In cells, negative allosteric modulation of SETDB1-mediated Akt methylation occurs after treatment with UNC10013. Therefore, UNC10013 is a potent, selective, and cell-active covalent ligand for the 3TD of SETDB1, demonstrating negative allosteric modulator properties and making it a promising tool to study the biological role of SETDB1 in disease progression.

引用

页数：16

共 50 条

[21] (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells
Barsyte-Lovejoy, Dalia
Li, Fengling
Oudhoff, Menno J.
Tatlock, John H.
Dong, Aiping
Zeng, Hong
Wu, Hong
Freeman, Spencer A.
Schapira, Matthieu
Senisterra, Guillermo A.
Kuznetsova, Ekaterina
Marcellus, Richard
Allali-Hassani, Abdellah
Kennedy, Steven
Lambert, Jean-Philippe
Couzens, Amber L.
Aman, Ahmed
Gingras, Anne-Claude
Al-Awar, Rima
Fish, Paul V.
Gerstenberger, Brian S.
Roberts, Lee
Benn, Caroline L.
Grimley, Rachel L.
Braam, Mitchell J. S.
Rossi, Fabio M. V.
Sudol, Marius
Brown, Peter J.
Bunnage, Mark E.
Owen, Dafydd R.
Zaph, Colby
Vedadi, Masoud
Arrowsmith, Cheryl H.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (35) : 12853 - 12858
[22] Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity
Ishimoto, Kenji
Kawamata, Natsuko
Uchihara, Yoshie
Okubo, Moeka
Fujimoto, Reiko
Gotoh, Eiko
Kakinouchi, Keisuke
Mizohata, Eiichi
Hino, Nobumasa
Okada, Yoshiaki
Mochizuki, Yasuhiro
Tanaka, Toshiya
Hamakubo, Takao
Sakai, Juro
Kodama, Tatsuhiko
Inoue, Tsuyoshi
Tachibana, Keisuke
Doi, Takefumi
PLOS ONE, 2016, 11 (10):
[23] Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents
Engers, Julie L.
Rodriguez, Alice L.
Konkol, Leah C.
Morrison, Ryan D.
Thompson, Analisa D.
Byers, Frank W.
Blobaum, Anna L.
Chang, Sichen
Venable, Daryl F.
Loch, Matthew T.
Niswender, Colleen M.
Daniels, J. Scott
Jones, Carrie K.
Conn, P. Jeffrey
Lindsley, Craig W.
Emmitte, Kyle A.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (18) : 7485 - 7500
[24] The CB1 negative allosteric modulator PSNCBAM-1 reduces ethanol self-administration via a nonspecific hypophagic effect
Buechler, Harley M.
Sumi, Mousumi
Madhuranthakam, Indu Mithra
Donegan, Christa
DiGiorgio Jr, Frank
Acosta, Alisha A.
Uribe, Sarah
Rahman, Mohammad A.
Sorbello, Alison
Fischer, Bradford D.
Keck, Thomas M.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2024, 240
[25] The CB1 Negative Allosteric Modulator PSNCBAM-1 Reduces Ethanol Self-Administration via a Nonspecific Hypophagic Effect
Keck, Thomas
Buechler, Harley
Sumi, Mousumi
DiGiorgio, Frank
Uribe, Sarah
Donnegan, Christa
Acosta, Alisha
Fischer, Bradford
FASEB JOURNAL, 2021, 35
[26] SETDB1 modulates PRC2 activity at developmental genes independently of H3K9 trimethylation in mouse ES cells
Fei, Qi
Yang, Xiaoqin
Jiang, Hua
Wang, Qian
Yu, Yanyan
Yu, Yiling
Yi, Wei
Zhou, Shaolian
Chen, Taiping
Lu, Chris
Atadja, Peter
Liu, Xiaole Shirley
Li, En
Zhang, Yong
Shou, Jianyong
GENOME RESEARCH, 2015, 25 (09) : 1325 - 1335
[27] An Unexpected Activity of a Minor Cannabinoid: Cannabicyclol (CBL) Is a Potent Positive Allosteric Modulator of Serotonin 5-HT1A Receptor
Haghdoost, Mehdi
Deporre, Yvonne
Figi, Max
Young, Scott
Krebs, Caitlyn
Bonn-Miller, Marcel O.
JOURNAL OF NATURAL PRODUCTS, 2025, 88 (01): : 58 - 66
[28] ADX71743, a Potent and Selective Negative Allosteric Modulator of Metabotropic Glutamate Receptor 7: In Vitro and In Vivo Characterization (vol 344, pg 624, 2013)
Kalinichev, M.
Rouillier, M.
Girard, F.
Royer-Urios, I
Bournique, B.
Finn, T.
Charvin, D.
Campo, B.
Le Poul, E.
Mutel, V
Poli, S.
Neale, S. A.
Salt, T. E.
Luetjens, R.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2013, 345 (02): : 328 - 328
[29] Discovery of a Potent and Selective Covalent Inhibitor and Activity-Based Probe for the Deubiquitylating Enzyme UCHL1, with Antifibrotic Activity
Panyain, Nattawadee
Godinat, Aurelien
Lanyon-Hogg, Thomas
Lachiondo-Ortega, Sofia
Will, Edward J.
Soudy, Christelle
Mondal, Milon
Mason, Katie
Elkhalifa, Sarah
Smith, Lisa M.
Harrigan, Jeanine A.
Tate, Edward W.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2020, 142 (28) : 12020 - 12026
[30] Pharmacokinetics of Fipaxalparant, a Small-Molecule Selective Negative Allosteric Modulator of Lysophosphatidic Acid Receptor 1, and the Effect of Food in Healthy Volunteers
Song, Yang
Ali, Farah N.
Ye, Zhan
Zarzoso, Jennifer
Rogowski, John
Sun, Yajing
Xin, Yan
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (07): : 819 - 827

← 1 2 3 4 5 →